Method for promoting in-vitro amplification of umbilical cord blood T cell and maintaining high-proportion TSCM subpopulation
A technology of umbilical cord blood and cell bodies, applied in the field of cytology
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] 1 Materials and methods
[0024] 1.1 Main reagents and instruments
[0025] Cycloastragenol (HPLC≥98%) was purchased from Chengdu Mansite Biological Company. RPMI1640 medium was purchased from Hyclone Company. Fetal Bovine Serum (FBS) was purchased from BOVOGEN Company. Lymphoprep lymphatic separation liquid was purchased from Axis-shield Company. Penicillin-streptomycin double antibody was purchased from Gibco. Interleukin 7 (IL-7) and interleukin 15 (IL-15) were purchased from Cellgenix. Dynabeads Human T-Activator CD3 / CD28 was purchased from Gibco. FITC anti-humanCD45RA, APC / cy7 anti-humanCD8, PE / cy7 anti-humanCD4, PE anti-humanCD197 (CCR7), PE anti-humanCD3, and CFSE were purchased from BD Company. ACEA NovoCyte series flow cytometer (ACEA NovoCyte 3130) was purchased from ACEA Biosciences. Low speed centrifuge, CO 2 The incubator was purchased from Thermo Fisher Company.
[0026] 1.1 1.2 Separation of Umbilical Cord Blood Mononuclear Cell (UCBMC)
[0027] H...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com